Article
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas
6 Aug 2020
Abstract excerpt
Abstract Background Immunotherapies targeting glioblastoma (GBM) have led to significant improvements in patient outcomes. TOX is closely associated with the immune environment surrounding tumors, but its role in gliomas is not fully understood. Methods Using data from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), we analyzed the transcriptomes of 1691 WHO grade I-IV human glioma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
